2nd Quarter - Report

CLARK & WEINSTOCK for ROCHE

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$10,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (this page) Jul 6, 2009 $10,000 Replaced
2nd Quarter - Amendment Jul 14, 2009 $10,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Lobbying on behalf of Roche's tamiflu initiative.

LobbyistCovered position, as disclosed
MELISSA M EDWARDS Professional Staff, Sen. Comm on Gov't Affairs
KIMBERLEY FARMER New —
ED KUTLER Assistant, House Republican Whip
G JOHN O'HANLON —
SANDRA K STUART Chief of Staff, Rep. Vic Fazio
VIN WEBER Member of Congress

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); SENATE

Medical/Disease Research/Clinical Labs MED

Lobbying on behalf of Roche's tamiflu initiative

LobbyistCovered position, as disclosed
MELISSA M EDWARDS —
KIMBERLEY FARMER New —
ED KUTLER —
G JOHN O'HANLON —
SANDRA K STUART —
VIN WEBER —

Contacted: Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.